Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Overexpression and Nucleolar Localization of γ-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma

E. Dráberová, L. D'Agostino, V. Caracciolo, V. Sládková, T. Sulimenko, V. Sulimenko, M. Sobol, NF. Maounis, E. Tzelepis, E. Mahera, L. Křen, A. Legido, A. Giordano, S. Mörk, P. Hozák, P. Dráber, CD. Katsetos,

. 2015 ; 74 (7) : 723-742.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031317

Grantová podpora
NT14467 MZ0 CEP - Centrální evidence projektů

The expression, cellular distribution, and subcellular sorting of the microtubule (MT)-nucleating γ-tubulin small complex (γTuSC) proteins, GCP2 and GCP3, were studied in human glioblastoma cell lines and in clinical tissue samples representing all histologic grades of adult diffuse astrocytic gliomas (n = 54). Quantitative real-time polymerase chain reaction revealed a significant increase in the expression of GCP2 and GCP3 transcripts in glioblastoma cells versus normal human astrocytes; these were associated with higher amounts of both γTuSC proteins. GCP2 and GCP3 were concentrated in the centrosomes in interphase glioblastoma cells, but punctate and diffuse localizations were also detected in the cytosol and nuclei/nucleoli. Nucleolar localization was fixation dependent. GCP2 and GCP3 formed complexes with γ-tubulin in the nucleoli as confirmed by reciprocal immunoprecipitation experiments and immunoelectron microscopy. GCP2 and GCP3 depletion caused accumulation of cells in G2/M and mitotic delay but did not affect nucleolar integrity. Overexpression of GCP2 antagonized the inhibitory effect of the CDK5 regulatory subunit-associated tumor suppressor protein 3 (C53) on DNA damage G2/M checkpoint activity. Tumor cell GCP2 and GCP3 immunoreactivity was significantly increased over that in normal brains in glioblastoma samples; it was also associated with microvascular proliferation. These findings suggest that γTuSC protein dysregulation in glioblastomas may be linked to altered transcriptional checkpoint activity or interaction with signaling pathways associated with a malignant phenotype.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031317
003      
CZ-PrNML
005      
20191022093700.0
007      
ta
008      
151005s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/NEN.0000000000000212 $2 doi
035    __
$a (PubMed)26079448
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dráberová, Eduarda $u From the Departments of Biology of Cytoskeleton (ED, VS, TS, VS, PD) and Biology of the Nucleus (MS, PH), Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Pediatrics (LD, ET, AL, CDK), Drexel University College of Medicine, Section of Pediatric Neurology and Neurooncology Program (AL, CDK), St. Christopher's Hospital for Children, and Department of Pathology and Laboratory Medicine (NFM, CDK) Drexel University College of Medicine, Philadelphia, Pennsylvania; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania (VC, AG); Department of Clinical Cytology, Sismanoglion General Hospital, Athens, Greece (NFM); Department of Pathology, KAT General Hospital, Athens, Greece (EM); Department of Pathology, Faculty Hospital Brno, Brno, Czech Republic (LK); and Gades Institute, Department of Pathology, University of Bergen, Haukeland Hospital, Bergen, Norway (SM). $7 xx0065234
245    10
$a Overexpression and Nucleolar Localization of γ-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma / $c E. Dráberová, L. D'Agostino, V. Caracciolo, V. Sládková, T. Sulimenko, V. Sulimenko, M. Sobol, NF. Maounis, E. Tzelepis, E. Mahera, L. Křen, A. Legido, A. Giordano, S. Mörk, P. Hozák, P. Dráber, CD. Katsetos,
520    9_
$a The expression, cellular distribution, and subcellular sorting of the microtubule (MT)-nucleating γ-tubulin small complex (γTuSC) proteins, GCP2 and GCP3, were studied in human glioblastoma cell lines and in clinical tissue samples representing all histologic grades of adult diffuse astrocytic gliomas (n = 54). Quantitative real-time polymerase chain reaction revealed a significant increase in the expression of GCP2 and GCP3 transcripts in glioblastoma cells versus normal human astrocytes; these were associated with higher amounts of both γTuSC proteins. GCP2 and GCP3 were concentrated in the centrosomes in interphase glioblastoma cells, but punctate and diffuse localizations were also detected in the cytosol and nuclei/nucleoli. Nucleolar localization was fixation dependent. GCP2 and GCP3 formed complexes with γ-tubulin in the nucleoli as confirmed by reciprocal immunoprecipitation experiments and immunoelectron microscopy. GCP2 and GCP3 depletion caused accumulation of cells in G2/M and mitotic delay but did not affect nucleolar integrity. Overexpression of GCP2 antagonized the inhibitory effect of the CDK5 regulatory subunit-associated tumor suppressor protein 3 (C53) on DNA damage G2/M checkpoint activity. Tumor cell GCP2 and GCP3 immunoreactivity was significantly increased over that in normal brains in glioblastoma samples; it was also associated with microvascular proliferation. These findings suggest that γTuSC protein dysregulation in glioblastomas may be linked to altered transcriptional checkpoint activity or interaction with signaling pathways associated with a malignant phenotype.
650    _2
$a zvířata $7 D000818
650    _2
$a žáby $7 D001001
650    _2
$a nádory mozku $x metabolismus $x patologie $x ultrastruktura $7 D001932
650    _2
$a buněčný cyklus $x fyziologie $7 D002453
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a buněčné jadérko $x metabolismus $7 D002466
650    _2
$a kur domácí $7 D002645
650    _2
$a poškození DNA $x genetika $7 D004249
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese u nádorů $x fyziologie $7 D015972
650    _2
$a glioblastom $x metabolismus $x patologie $x ultrastruktura $7 D005909
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a proteiny asociované s mikrotubuly $x genetika $x metabolismus $7 D008869
650    _2
$a lidé středního věku $7 D008875
650    _2
$a transport proteinů $7 D021381
650    _2
$a tubulin $x metabolismus $7 D014404
650    _2
$a nádorový supresorový protein p53 $x metabolismus $7 D016159
650    _2
$a mladý dospělý $7 D055815
650    _2
$a dánio pruhované $7 D015027
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a D'Agostino, Luca
700    1_
$a Caracciolo, Valentina
700    1_
$a Sládková, Vladimíra
700    1_
$a Sulimenko, Tetyana $7 xx0117681
700    1_
$a Sulimenko, Vadym $7 xx0117682
700    1_
$a Sobol, Margaryta
700    1_
$a Maounis, Nicoletta F
700    1_
$a Tzelepis, Elias
700    1_
$a Mahera, Eleni
700    1_
$a Křen, Leoš, $d 1966- $7 xx0081918
700    1_
$a Legido, Agustin
700    1_
$a Giordano, Antonio
700    1_
$a Mörk, Sverre
700    1_
$a Hozák, Pavel, $d 1958- $7 js20040517003
700    1_
$a Dráber, Pavel $7 xx0065228
700    1_
$a Katsetos, Christos D
773    0_
$w MED00010065 $t Journal of neuropathology and experimental neurology $x 1554-6578 $g Roč. 74, č. 7 (2015), s. 723-742
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26079448 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20191022094134 $b ABA008
999    __
$a ok $b bmc $g 1092193 $s 914443
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 74 $c 7 $d 723-742 $i 1554-6578 $m Journal of neuropathology and experimental neurology $n J Neuropathol Exp Neurol $x MED00010065
GRA    __
$a NT14467 $p MZ0
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace